Federal Circuit Upholds Board In Dispute Over Multiple Sclerosis Treatment

Mealey's (October 24, 2018, 1:29 PM EDT) -- WASHINGTON, D.C. — In an Oct. 24 ruling, the Federal Circuit U.S. Court of Appeals agreed with the Patent Trial and Appeal Board that a patent application covering the controlled release...
To view the full article, register now.